183 related articles for article (PubMed ID: 30723749)
1.
Machado-Sulbaran AC; Ramírez-Dueñas MG; Navarro-Zarza JE; Muñoz-Valle JF; Mendoza-Carrera F; Baños-Hernández CJ; Parra-Rojas I; Montoya-Buelna M; Sánchez-Hernández PE
J Immunol Res; 2019; 2019():6808061. PubMed ID: 30723749
[TBL] [Abstract][Full Text] [Related]
2. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
[TBL] [Abstract][Full Text] [Related]
3. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
[TBL] [Abstract][Full Text] [Related]
4. The investigation of killer cell immunoglobulin-like receptor genotyping in patients with systemic lupus erytematosus and systemic sclerosis.
Tozkır JD; Tozkır H; Gürkan H; Dönmez S; Eker D; Pamuk GE; Pamuk ÖN
Clin Rheumatol; 2016 Apr; 35(4):919-25. PubMed ID: 26960450
[TBL] [Abstract][Full Text] [Related]
5. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
[TBL] [Abstract][Full Text] [Related]
6. Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis.
Salim PH; Jobim M; Bredemeier M; Chies JA; Schlottfeldt J; Brenol JC; Jobim LF; Xavier RM
Clin Exp Immunol; 2010 Jun; 160(3):325-30. PubMed ID: 20082621
[TBL] [Abstract][Full Text] [Related]
7. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
[TBL] [Abstract][Full Text] [Related]
8. Positive association of Bx genotype, KIR2L5, KIR2DS5 and full-length KIR2DS4 with the risk of meningioma.
Barani S; Taghipour M; Ghaderi A
Immunobiology; 2020 Mar; 225(2):151900. PubMed ID: 31899050
[TBL] [Abstract][Full Text] [Related]
9. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
[TBL] [Abstract][Full Text] [Related]
10. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors.
Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D
Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859
[TBL] [Abstract][Full Text] [Related]
11. Activating KIR/HLA-I combinations as a risk factor of adult B-ALL.
Halimi H; Mirzazadeh S; Kalantar K; Hajimaghsoodi M; Ramzi M; Farjadian S
Hum Immunol; 2024 Mar; 85(2):110750. PubMed ID: 38262874
[TBL] [Abstract][Full Text] [Related]
12. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
[TBL] [Abstract][Full Text] [Related]
13. The impact of KIR-HLA genotype on hepatitis B virus clearance in Iranian infected individuals.
Shah-Hosseini A; Jafari M; Mohammadi A; Sanaei R; Alavian SM; Doosti-Irani A; Nooradeh Keykavousi M; Tajik N
Med Microbiol Immunol; 2017 Dec; 206(6):463-470. PubMed ID: 29032460
[TBL] [Abstract][Full Text] [Related]
14. KIR genes and HLA class I ligands in Gaucher disease.
Vairo F; Portela P; Salim PH; Jobim M; Netto C; Dorneles A; Mittlestadt S; Jobim LF; Schwartz IV
Gene; 2013 Mar; 516(1):53-7. PubMed ID: 23266622
[TBL] [Abstract][Full Text] [Related]
15. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans.
Du Z; Gjertson DW; Reed EF; Rajalingam R
Immunogenetics; 2007 Jan; 59(1):1-15. PubMed ID: 17103212
[TBL] [Abstract][Full Text] [Related]
16. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
[TBL] [Abstract][Full Text] [Related]
17. Analysis of KIR gene frequencies and HLA class I genotypes in breast cancer and control group.
Jobim MR; Jobim M; Salim PH; Portela P; Jobim LF; Leistner-Segal S; Bittelbrunn AC; Menke CH; Biazús JV; Roesler R; Schwartsmann G
Hum Immunol; 2013 Sep; 74(9):1130-3. PubMed ID: 23792055
[TBL] [Abstract][Full Text] [Related]
18. Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study.
Varbanova VP; Mihailova S; Naumova E; Mihaylova AP
Turk J Haematol; 2019 Nov; 36(4):238-246. PubMed ID: 31337191
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases.
Beigmohammadi F; Mahmoudi M; Karami J; Ahmadzadeh N; Ebrahimi-Daryani N; Rezaei N
J Immunol Res; 2020; 2020():4873648. PubMed ID: 33015197
[TBL] [Abstract][Full Text] [Related]
20. A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia.
Sheereen A; Gaafar A; Iqneibi A; Eldali A; Tabbara KF; Adra C; Al-Hussein K
Mol Vis; 2011; 17():3523-8. PubMed ID: 22219647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]